Innovation in mRNA Vaccines and RNAi via Protein Nanocages

Area of Science:

• Biotechnology
• Nanotechnology
• Immunology

Background:

• Self-assembling protein nanocages (SAPNs) are natural structures built from identical subunits.
• They offer internal cargo encapsulation and external surface modification capabilities.
• SAPNs are explored for vaccine development and RNA interference (RNAi) therapy.

Purpose of the Study:

• To review the structural and functional properties of SAPNs.
• To examine SAPN applications in vaccine design (subunit, mRNA, DNA) and RNAi delivery.
• To highlight SAPNs' potential against viral infections.

Main Methods:

• Review of existing literature on SAPN structure, function, and applications.
• Analysis of SAPN integration strategies for different vaccine types (subunit, mRNA, DNA).
• Evaluation of SAPN-based RNAi delivery mechanisms.

Main Results:

• SAPNs enhance vaccine stability, antigen presentation, and immune activation.
• SAPN-RNA vaccines improve efficacy, reduce off-target effects, and lower required doses.
• SAPNs facilitate antigen-adjuvant co-delivery and improve siRNA delivery for RNAi.

Conclusions:

• SAPNs are a versatile platform for subunit, mRNA, and DNA vaccines, adjuvant delivery, and RNAi therapeutics.
• Functionalization with adjuvants or targeting ligands enhances immunostimulatory properties and specificity.
• SAPNs show significant potential for combating viral infections.